SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 133 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,378,664 | -53.6% | 614,642 | -28.5% | 0.00% | -100.0% |
| Q2 2023 | $5,121,124 | +60.4% | 859,249 | -12.0% | 0.00% | 0.0% |
| Q1 2023 | $3,191,828 | -56.7% | 976,094 | -47.6% | 0.00% | -50.0% |
| Q4 2022 | $7,364,767 | -13.0% | 1,864,498 | +32.2% | 0.00% | 0.0% |
| Q3 2022 | $8,466,000 | +54.7% | 1,410,868 | +65.8% | 0.00% | +100.0% |
| Q2 2022 | $5,472,000 | +11.3% | 851,027 | +43.0% | 0.00% | 0.0% |
| Q1 2022 | $4,917,000 | -18.5% | 595,289 | +52.8% | 0.00% | 0.0% |
| Q4 2021 | $6,030,000 | -2.0% | 389,493 | +42.5% | 0.00% | 0.0% |
| Q3 2021 | $6,155,000 | -14.9% | 273,325 | -25.7% | 0.00% | -50.0% |
| Q2 2021 | $7,235,000 | +37.9% | 367,988 | +134.7% | 0.00% | +100.0% |
| Q1 2021 | $5,248,000 | – | 156,786 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $220,158,000 | 8.29% |
| Crestline Management, LP | 3,365,624 | $21,641,000 | 2.82% |
| Omega Fund Management, LLC | 843,750 | $5,425,000 | 1.73% |
| Alphabet Inc. | 2,812,500 | $18,084,000 | 0.98% |
| HARVARD MANAGEMENT CO INC | 468,749 | $3,014,000 | 0.35% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 6,400,000 | $41,152,000 | 0.35% |
| PFM Health Sciences, LP | 952,733 | $6,126,000 | 0.23% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 156,254 | $1,005,000 | 0.20% |
| Viewpoint Capital Management LLC | 23,545 | $151,000 | 0.14% |
| Artal Group S.A. | 400,000 | $2,572,000 | 0.14% |